The potential of a new larviciding method for the control of malaria vectors

Gregor J Devine & Gerry F Killeen | 25 May 2023 | Malaria Journal

Malaria pathogens are transmitted to humans by the bite of female Anopheles mosquitoes. The juvenile stages of these mosquitoes develop in a variety of water bodies and are key targets for vector control campaigns involving the application of larvicides.

Do we still need a malaria vaccine?

B. Greenwood & G. Targett | 27 Aug 2023 | Parasite Immunology

An unexpectedly large reduction in the burden of malaria has recently been achieved in a number of malaria endemic countries following the scaling up of effective treatment and simple vector control programmes.

Bias & Neglect - Public Health Insecticides & Disease Control

None | 17 Dec 2023 | Africa Fighting Malaria

Insecticides are a vital component of disease control. To a great extent the modern insect-borne disease burden of hundreds of millions of human infections results from failures to use the chemicals we characterize as public health insecticides (PHIs). The modern arsenal of PHIs is antiquated and limited to just 12 insecticides, most belonging to just one class of insecticides (pyrethroids).

The Malaria Atlas Project: Developing Global Maps of Malaria Risk

Simon I. Hay & Robert W. Snow | 05 Dec 2023 | PloS Medicine

In allocating public health resources, the guiding principle should be an evidence-based quantification of need. A significant effort to categorize diseases by their global morbidity and mortality impact has developed during the last decade, epitomized by the Global Burden of Diseases and the Disease Control Priorities projects. But despite these efforts, the evidence base for allocating resources for malaria control on a global scale is poor. 

The Rise, Fall, Rise, and Imminent Fall of DDT

Roger Bate | 05 Nov 2023 | American Enterprise Institute

DDT is probably the single most valuable chemical ever synthesized to prevent disease. It has been used continually in public health programs over the past sixty years and has saved millions from diseases like malaria, typhus, and yellow fever. Despite a public backlash in the 1960s, mainstream scientific and public health communities continue to recognize its utility and safety.

Government-Controlled Research & Development - A Recipe for Disaster

Roger Bate & Richard Tren | 22 May 2023 | American Enterprise Institute

This paper warns against the proposed May 2006 World Health Assembly treaty to increase state control of research and development into new drugs.

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

Pedro L. Alonso et al | 16 Oct 2023 | The Lancet

Development of an effective malaria vaccine could greatly contribute to disease control. RTS,S/AS02A is a pre-erythrocytic vaccine candidate based on Plasmodium falciparum circumsporozoite surface antigen. We aimed to assess vaccine efficacy, immunogenicity, and safety in young African children.

IREN Workshop Paper

Richard Tren | 19 Mar 2024 | Africa Fighting Malaria

Among the most widely debated topics currently relates to the issue of healthcare, globalisation and intellectual property rights (IPR). Intellectual property rights refer to the property in ideas or in their expression. This paper will mainly discuss one particular form of IPR, patents and in particular patents for medicines and the relations between this type of IPR and access to medicines.